Shanthi Ganesh

Director at Novo Nordisk

Speaker

Shanthi is the Senior Scientific Director at Novo Nordisk, with over 20 years of industry experience spanning nucleic acid therapeutics, drug delivery, cancer drug discovery, and gene therapy. She played a key role in advancing the first two RNAi-lipid conjugates into clinical development for the treatment of cancer patients at Novo Nordisk and is currently focused on evaluating clinical candidates for chronic inflammatory diseases. Previously at NIBR and other gene therapy companies, she focused on developing RNAi therapeutics and oncolytic viruses for cancer treatment. She has numerous publications, including 13 first-author papers and holds several patents and awards recognizing her contributions. She has been an active member of the AACR and Endocrine Society and has presented her work at numerous international conferences. She earned her Ph.D. from Northeastern University, specializing in siRNA delivery and RNAi therapeutics for cancer applications.